Prescrire les collyres fortifiés
- 1 April 2007
- journal article
- abstracts
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 30 (4), 423-430
- https://doi.org/10.1016/s0181-5512(07)89618-5
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothinClinical & Experimental Ophthalmology, 2006
- The Fixed Combination of Fortified Vancomycin and Amikacin Ophthalmic Solution-VA SolutionCornea, 2005
- Management of bacterial keratitis: beyond exorcism towards consideration of organism and host factorsEye, 2003
- Suppurative keratitisBritish Journal of Ophthalmology, 2003
- Worldwide Prevalence of Antimicrobial Resistance inStreptococcus pneumoniae, Haemophilus influenzae,andMoraxella catarrhalisin the SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001
- Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolonesOphthalmology, 2000
- In vitro antibiotic resistance in bacterial keratitis in LondonBritish Journal of Ophthalmology, 2000
- Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitisEye, 1999
- Strategies for the management of microbial keratitis.British Journal of Ophthalmology, 1995
- The Effect of Topical Ceftazidime on Pseudomonas Keratitis in RabbitsCornea, 1994